BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15345317)

  • 1. The novel histone deacetylase inhibitor BL1521 inhibits proliferation and induces apoptosis in neuroblastoma cells.
    de Ruijter AJ; Kemp S; Kramer G; Meinsma RJ; Kaufmann JO; Caron HN; van Kuilenburg AB
    Biochem Pharmacol; 2004 Oct; 68(7):1279-88. PubMed ID: 15345317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitor BL1521 induces a G1-phase arrest in neuroblastoma cells through altered expression of cell cycle proteins.
    Ouwehand K; de Ruijter AJ; van Bree C; Caron HN; van Kuilenburg AB
    FEBS Lett; 2005 Feb; 579(6):1523-8. PubMed ID: 15733867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling in response to the histone deacetylase inhibitor BL1521 in neuroblastoma.
    de Ruijter AJ; Meinsma RJ; Bosma P; Kemp S; Caron HN; van Kuilenburg AB
    Exp Cell Res; 2005 Oct; 309(2):451-67. PubMed ID: 16084510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
    Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells.
    Hsi LC; Xi X; Lotan R; Shureiqi I; Lippman SM
    Cancer Res; 2004 Dec; 64(23):8778-81. PubMed ID: 15574791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma.
    Glick RD; Swendeman SL; Coffey DC; Rifkind RA; Marks PA; Richon VM; La Quaglia MP
    Cancer Res; 1999 Sep; 59(17):4392-9. PubMed ID: 10485488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemia.
    Romanski A; Bacic B; Bug G; Pfeifer H; Gul H; Remiszewski S; Hoelzer D; Atadja P; Ruthardt M; Ottmann OG
    Haematologica; 2004 Apr; 89(4):419-26. PubMed ID: 15075075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cells.
    Wegener D; Deubzer HE; Oehme I; Milde T; Hildmann C; Schwienhorst A; Witt O
    Anticancer Drugs; 2008 Oct; 19(9):849-57. PubMed ID: 18765999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells.
    Mandl-Weber S; Meinel FG; Jankowsky R; Oduncu F; Schmidmaier R; Baumann P
    Br J Haematol; 2010 May; 149(4):518-28. PubMed ID: 20201941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.
    Heider U; Kaiser M; Sterz J; Zavrski I; Jakob C; Fleissner C; Eucker J; Possinger K; Sezer O
    Eur J Haematol; 2006 Jan; 76(1):42-50. PubMed ID: 16343270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of histone deacetylases by chlamydocin induces apoptosis and proteasome-mediated degradation of survivin.
    De Schepper S; Bruwiere H; Verhulst T; Steller U; Andries L; Wouters W; Janicot M; Arts J; Van Heusden J
    J Pharmacol Exp Ther; 2003 Feb; 304(2):881-8. PubMed ID: 12538846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.
    Vigushin DM; Ali S; Pace PE; Mirsaidi N; Ito K; Adcock I; Coombes RC
    Clin Cancer Res; 2001 Apr; 7(4):971-6. PubMed ID: 11309348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation.
    Park JH; Jung Y; Kim TY; Kim SG; Jong HS; Lee JW; Kim DK; Lee JS; Kim NK; Kim TY; Bang YJ
    Clin Cancer Res; 2004 Aug; 10(15):5271-81. PubMed ID: 15297431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fission yeast-based screening to identify putative HDAC inhibitors using a telomeric reporter strain.
    Chung KS; Ahn J; Choi CH; Yim NH; Kang CM; Kim CH; Lee K; Park HM; Song KB; Won M
    Mol Cells; 2008 Jul; 26(1):93-9. PubMed ID: 18525239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel isoform-selective inhibitors within class I histone deacetylases.
    Hu E; Dul E; Sung CM; Chen Z; Kirkpatrick R; Zhang GF; Johanson K; Liu R; Lago A; Hofmann G; Macarron R; de los Frailes M; Perez P; Krawiec J; Winkler J; Jaye M
    J Pharmacol Exp Ther; 2003 Nov; 307(2):720-8. PubMed ID: 12975486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells.
    Ahn MY; Jung JH; Na YJ; Kim HS
    Gynecol Oncol; 2008 Jan; 108(1):27-33. PubMed ID: 17920664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells.
    Choi YH
    Int J Oncol; 2005 Aug; 27(2):473-9. PubMed ID: 16010430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin.
    Han JW; Ahn SH; Park SH; Wang SY; Bae GU; Seo DW; Kwon HK; Hong S; Lee HY; Lee YW; Lee HW
    Cancer Res; 2000 Nov; 60(21):6068-74. PubMed ID: 11085529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells.
    Donadelli M; Costanzo C; Faggioli L; Scupoli MT; Moore PS; Bassi C; Scarpa A; Palmieri M
    Mol Carcinog; 2003 Oct; 38(2):59-69. PubMed ID: 14502645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel histone deacetylase inhibitors in the treatment of thyroid cancer.
    Mitsiades CS; Poulaki V; McMullan C; Negri J; Fanourakis G; Goudopoulou A; Richon VM; Marks PA; Mitsiades N
    Clin Cancer Res; 2005 May; 11(10):3958-65. PubMed ID: 15897598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.